AzTrials
AzTrials

ADHDPhase 2/3STAND-GNCT05386251

Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges

A Phase 2/3 study testing BPT/OST and Peer Support in people with ADHD, run by Seattle Children's Hospital.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this study is to test the effectiveness of a telehealth-delivered skills training versus active control group for middle and high school students with ADHD symptoms. Both programs will be delivered digitally (via Zoom). Read more about this study

Who is it for?
Ages 11 to 17 years
Conditions the study is for
ADHD
What is being tested?
BPT/OST and Peer Support
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
No sites listed yet
Study dates
18 May 2022to 30 Sep 2022
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Students will be required to,
  • be in the sixth through twelfth grade,
  • have elevated ADHD symptoms
  • documented impairment according to the SNAP
  • documented impairment according to Impairment Rating Scale.
  • Students must be 17.5 or younger at the time of enrollment to ensure that they are still under 18 at the expected completion of the study.
  • Parents of eligible students will also participate.

Who cannot join

  • Students may not be,
  • in a self-contained special education classroom,
  • possess intellectual disability
  • be non-English speaking
  • be older than 18 years old at time of enrollment

About this study

The purpose of this study is to test the effectiveness of a telehealth-delivered skills training versus active control group for middle and high school students with ADHD symptoms. Both programs will be delivered digitally (via Zoom).

Investigators will measure student functioning at baseline, post-group, and three-month follow-up. The primary outcomes are ADHD symptoms, student grade point average, and attendance as reported in the gradebook. Secondary outcomes include parent academic support, autonomy, academic motivation, and organization skills. Participant satisfaction with the group will be measured post-group. Group attendance and homework completion will also be measured.

Read the detailed description

120 middle and high school students with elevated ADHD symptoms will be recruited for this study, which will take place over the course of the 2021-2022 academic year. The recruitment strategy will be to distribute information about the study opportunity to educator email lists in South Florida (see appended email template). Educators will be instructed to share information about the study to the parents of students who perceive to experience ADHD symptoms in their schools, regardless of special education status or documentation of a disability.

Students who enroll will be randomly assigned to either receive the STAND-G strategy-based group or a peer-support-based, active control group. Investigators will blind participants and their parents to which group is the active treatment by informing parents and students that participant will be randomly assigned to one of two groups to help improve school difficulties in youth. The two groups will be of equal duration, both will be led by the same instructors; and will differ only in content (teaching strategies vs. facilitating peer support and problem-solving conversations).

Students (and their parents) will complete assessments at baseline, post-group, and three months post-group. School records will be obtained for all time points.

Conditions
ADHD
Being tested
BPT/OST, Peer Support
Keywords
ADHD, Behavioral Intervention, Telehealth
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BPT/OSTBehavioural

    Also called STAND-Group

    See Arm description.

  • Peer SupportBehavioural

    See Arm description

Study groups in NCT05386251
Study groupRoleWhat they receive
Behavioral Parent Training/Organization Skills TrainingExperimentalParents will receive 8 weeks of a 90 minute behavioral parent training protocol that focuses on supporting academic and behavioral success in adolescents with ADHD. Teens will receive a simultaneous 8 weeks of a 90 minute organization skills training group. Both groups will be delivered via telehealth.
Receives: Behavioral: BPT/OST
Peer supportSham comparatorParents and teens will each participate in 8 weeks of a 90 minute peer support group focused on exchange of shared experience and group problem-solving difficulties. Both groups will be delivered via telehealth.
Receives: Behavioral: Peer Support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ADHD Symptoms

    Parent and Self Ratings on the SNAP Rating Scale, SNAP (0-3)

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  2. Academic Impairment: Grade Point Average

    Official School Records

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  3. Academic Impairment: School Attendance

    Official School Records

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

Secondary outcomes (9)
  1. Academic Motivation

    Expectancy-Value Questionnaire -Self Version, (1-5) Higher scores can mean better outcome

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  2. Academic Motivation

    Change Ruler -Self Version

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  3. Executive Functions

    BRIEF Rating Scale -Parent Version, BRIEF

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  4. Organization, Time Management, and Planning

    Adolescent Academic Problems Checklist-Parent and Self Version will be used to measure organization, time management and planning, AAPC

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  5. Parent Academic Involvement

    Parent Academic Management Scale - Parent Version, PAMS (0-5) Higher scores can mean better outcome

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  6. Academic Impairment Rating Scale

    Impairment Rating Scale - Parent Version

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  7. Parent-Teen Conflict

    Conflict Behavior Questionnaire-20 - Parent, Self Version, CBQ

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  8. Goal Setting

    Goal Setting Questionnaire- Parent and Self

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

  9. Parent Autonomy Support

    Parent Promotion of Volitional Functioning- Self Report

    Measured: Change from Baseline through 3 months after Post-Treatment, an average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2022
  2. Study start18 May 2022
  3. Primary completion30 Sep 2022 (estimated)
  4. Study completion30 Sep 2022 (estimated)

Why it stopped: Lack of resources

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Students are randomized in a 1:1 allocation ratio to the active treatment of the control group. Participants will be randomized to the strategies or peer support groups using a stratified randomization procedure that randomizes within grade level (i.e., middle school or high school). After 20 students are randomized to a group, the group will be scheduled to begin.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05386251
Sponsor's protocol ID
00003308
Acronym
STAND-G
Status last verified
Apr 2026
First submitted
24 Sep 2021
Last updated
24 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will submit data from this trial to the OSF data repository upon completion of the trial.

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing BPT/OST and Peer Support in people with ADHD, run by Seattle Children's Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 24 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ADHD Symptoms (time frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in